AirLife, a prominent manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, has successfully completed its acquisition of Avanos Medical, Inc.’s respiratory health business, which includes the BALLARD, MICROCUFF, and endOclear product lines. This acquisition represents a significant addition to AirLife’s portfolio, including the research and development expertise behind these brands and two manufacturing facilities.
Key points about AirLife’s acquisition of Avanos Medical’s respiratory health business:
- Complementary Brands: The acquisition adds three complementary brands to AirLife’s portfolio. These brands, including BALLARD, MICROCUFF, and endOclear, are trusted names in the field of closed suction and endotracheal consumables used to treat patients in critical care.
- Enhancing Leadership: AirLife’s CEO, Hank Struik, expressed excitement about strengthening AirLife’s leadership position as a premier consumable breathing products company. This acquisition allows AirLife to expand its portfolio of trusted products in anesthesia and respiratory care.
- Growth and Innovation: The addition of these brands and their associated teams opens up new growth opportunities for AirLife. It also provides the company with the potential to drive innovation across its comprehensive portfolio of leading brands, ultimately supporting better patient outcomes.
AirLife, formerly known as SunMed, is headquartered in Grand Rapids, Michigan, with manufacturing and distribution sites in the United States, Mexico, China, and Europe. The company offers a wide range of consumable anesthesia and respiratory care products designed to serve the continuum of care, from first responders to hospitals and home care. AirLife’s portfolio includes renowned brands such as Salter Labs, Ethox Medical, Ventlab, Westmed, AirLife, and Vital Signs. The company has over 1 million square feet of manufacturing space and a comprehensive expertise in plastics materials and conversion.
Frazier Healthcare Partners, a leading healthcare investment firm, acquired a majority ownership stake in AirLife in 2021. This acquisition reflects AirLife’s commitment to expanding its product offerings and serving healthcare practitioners with high-quality consumable breathing solutions.
